CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 154 enrolled
Drug / intervention
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG) +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03887299
NCT03887299Phase 4Completed
CompareCT.gov

Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery: A Randomized Control Trial

The University of Texas Medical Branch, Galveston·interventional·Posted Mar 22, 2019·Updated Oct 5, 2021

In Brief

A Phase 4 clinical trial evaluating ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG) and Standard Wound Care for Cesarean Section Complications and 4 related conditions. Completed, enrolled 154 participants across 1 site.

Detailed Summary

This will be an open label pilot randomized controlled clinical trial. Women undergoing cesarean delivery will be randomized to have standard wound dressing care or chlorohexidine gluconate (CHG) impregnated wound dressing (ReliaTect™ Post-Op Dressing).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCesarean Section Complications, Wound Breakdown, Wound Infection, Satisfaction, Surgical Wound Infection
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedMar 22, 2019
Enrollment StartApr 18, 2019
Primary CompletionJan 18, 2020
Study CompletionFeb 28, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.3 years ago

Interventions

ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG)combination

Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7

Standard Wound Careother

Wound care will be administered as standard protocol in our institution